Tag Archives: BIO Investor Forum

Promising vaccine companies set to take the stage at BIO Investor Forum

BIF_logo

It is no secret that vaccines are a hot space in biotech right now, and the 13th Annual BIO Investor Forum will feature several companies working on promising vaccine R&D. The event, scheduled for October 7-8 in San Francisco, Calif., will feature 120 late-stage private and emerging public company presentations. Attendees at the BIO Investor Forum will hear from Immunovaccine, a clinical-stage vaccine development company focused on product candidates for cancer therapy, infectious disease and Read More >

Events, Health  |  Leave a comment  |  Email This Post
Tags: , , , , , , ,

Buzz of BIO to recognize the most innovative companies at the 2014 BIO Investor Forum™

BIF-BuzzofBIO-116x76

Nominations are now open for the Buzz of BIO at the 2014 BIO Investor Forum. The Buzz of BIO contest recognizes highly innovative companies in the biotech sector and helps position these companies to develop strategic partnerships within the industry. Ten biotechs will be nominated in each of two categories – Early Stage Entrepreneurs and Late Stage Leaders. Early-stage companies looking for their next financing round or late-stage private companies hoping to make the valuable Read More >

Events  |  Leave a comment  |  Email This Post
Tags: , , , , ,

Biotech CEOs Speak Out on JOBS Act Success

Biotech IPOs Infographic

Enacted in April 2012, the Jumpstart Our Business Startups (JOBS) Act makes the pathway to capital formation more attainable for small biotechnology companies, clearing the way for American innovation and ingenuity by removing bureaucratic hurdles and red tape to speed cures and medical breakthroughs to patients. The JOBS Act reached a major milestone last week, with the 100th company going public under its provisions. On October 7th at the 13th Annual BIO Investor Forum, we Read More >

Events  |  Leave a comment  |  Email This Post
Tags: , , , , , , ,

Looking Ahead to the 2014 BIO Investor Forum, Biotech IPO Hopefuls Continue to Seek Funding

partnering1

As mentioned in Fierce Biotech, a new crop of biotech IPO hopefuls have recently thrown their hats into the ring. These three biotechs are targeting $175M in IPO cash, hoping to secure funding for oncology, pain, and rare diseases. In fact, there have been 96 IPOs since the passage of the JOBS Act in April of 2012. One important provision of the Act is the ability for emerging growth companies to conduct “testing the waters” meetings with Read More >

Events  |  Leave a comment  |  Email This Post
Tags: , , , , ,

Lots of Buzz at the BIO Investor Forum

Event

Thirty-eight biotech IPO’s this year. The NASDAQ Biotechnology Index is up 50 percent YTD.  Are we in a boom or a bubble? At the 12th Annual BIO Investor Forum,  that was the question on everybody’s mind. Nearly 600 biotech industry leaders, investors, and reporters gathered in San Francisco to find business partners, make connections, and hear our panelists discuss everything from Crowdfunding, the GAIN Act, the JOBS Act, and, of course, the booming IPO markets. Read More >

Events  |  Leave a comment  |  Email This Post
Tags: , , , , , , ,